The therapeutic applications of peptides are increasingly attracting attention and popularity in the United States. Globally, the peptide therapeutics market currently stands at $28 billion and is projected to surpass $50 billion by 2024, driven by augmented research and development investments from major pharmaceutical organizations. The widespread acceptance of peptides, coupled with their specificity to intended functions and a high safety profile well-tolerated by patients, makes these therapies practical.
Peptide treatments are experiencing growth across various medical domains, such as weight loss (muscle preservation), immune system disorders, growth hormone regulation, and enhancing skin appearance through both topical and injectable methods. Peptides also play a role in addressing injuries, combating certain diseases, and contributing to anti-aging efforts while improving overall performance. As chains of amino acids linked by polypeptide bonds, the targeted use of peptides influences the body's endocrine and immune systems. Notably, there are over 2 million articles on the use of peptides on PubMed alone, underscoring the extensive research and interest in this field.
